Briefly discuss diseases associated with signal transduction.
These either lead to gain of function (ligand not needed) or loss of function.
Retinitis pigmentosa - loss of function
Familial male precocious puberty - gain of function
Nephrogenic diabetes insipidus - loss of function
Describe the structure of GPCRs
What is the configuration of GPCRs in their basal state?
Alpha subunit is bound to BY complex, with GDP bound to the alpha. (It is the association of GDP with the alpha that increases the affinity for the BY of the A subunit).
Describe the conformational change of the GPCR upon ligand binding, and the fate of the subunits.
Ligand bind:
Explain how the length of activation of GPCRs is governed.
How does the termination of action of the GPCR occur?
Via intrinsic GTPase activity of the A subunit.
Describe what happens after the activation of Adenylyl cyclase
When Gs is actviated, there is an increase in Adenylyl cyclase.
AC hydrolyses ATP to cAMP.
cAMP interacts with PKA (dependent on cAMP)
PKA phosphorylates other proteins that have stimulatory or inhibitory effects.
AC can also be inhibited, when the receptor Gi is activated.
Describe what happens when Gq is activated.
Describe the cellular sequence of events when Noradrenaline binds to B1 adrenoreceptors.
Describe the effect of noradrenaline activation of A1-adrenoreceptors
Describe what happens with the activation of M2 receptors in the SAN
For the recognition of an external signalling molecule, what must a cell have?
A receptor.
This binding of the ligand can then activate the cell, either directly or indirectly.